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We have previously observed that a polyoma-mouse chimeric DNA molecule (RmI) in which the murine DNA insert is
flanked by directly repeated viral sequences is effectively converted into unit-length polyoma DNA upon transfection of
permissive mouse cells. This intramolecular recombination event appears to be dependent on VmP1, a protein encoded by
RmI which includes the 328 N-terminal amino acids of polyoma VP1, and nine amino acids of murine origin carrying the
C-terminus of the protein. We report here that introducing mutations into the VP2/VP3 coding sequence reduces the ability
of RmI to generate polyoma DNA, even though the same mutations seem to exert little or no effect on the ability of polyoma
DNA to either replicate or accumulate inside transfected cells. A mutation affecting VP2 alone being as effective as one that
affects both VP2 and VP3, VP2 appears to be playing a critical role in recombination. © 2000 Academic PressINTRODUCTION
During productive infection by polyoma virus, three
viral structural proteins, VP1, VP2, and VP3, are trans-
lated from distinct mRNAs (Siddell and Smith, 1978). VP2
and VP3 being encoded by sequences which overlap
largely and translated from the same reading frame, the
entire amino acid (aa) sequence of VP3 is identical to the
carboxyl-terminal two-thirds of VP2; in contrast, the gene
for the “major” late protein VP1 is translated from a
different reading frame and overlaps the 39 end of the
equence encoding the “minor” proteins by only 30 nu-
leotides (Griffin et al., 1974; Soeda et al., 1980b). The
hort sequence specifying both the C-terminus of VP2
nd VP3 and the N-terminus of VP1 also encodes the
uclear localization signals (NLS) for all three proteins
Chang et al., 1992a, 1992b; Moreland and Garcea, 1991),
s well as a stretch of aa essential to the DNA-binding
ctivity of VP1 (Chang et al., 1993; Moreland et al., 1991).
VP1, VP2, and VP3 interact physically and functionally
well before they are incorporated into the virion. For
instance, coexpression of these proteins in the cyto-
plasm enhances their transfer to the nucleus (Cai et al.,
1994; Delos et al., 1993; Forstova et al., 1993), and coex-
pression with VP2 is required for physiological modifica-
tion of VP1 (Forstova et al., 1993; Li et al., 1995). VP2 and
VP3 have also been shown to interact in vitro with re-
combinant VP1 pentamers (Delos et al., 1995). Using an
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122in vitro assay, it was found that a 42 aa sequence located
near the carboxyl terminus of VP2 and VP3 strongly binds
VP1; VP1 being assembled shortly after synthesis into
pentamers that become capsomeres in the virus particle,
each VP1 pentamer appears to bind either one VP2
monomer or one VP3 monomer (Barouch and Harrison,
1994). Recently, the hydrophobic interactions between
the 42 aa sequence in VP2 and the VP1 pentamer have
been the subject of a crystallographic study which indi-
cated that most of the aa of VP1 involved in the interac-
tion with VP2 are clustered within a relatively short se-
quence (Chen et al., 1998). Thus, the 62 aa proximal to
the carboxyl terminus of VP1 do not seem to be required
for interaction of this protein with VP2 or VP3 (Chen et al.,
1998; Delos et al., 1995, Garcea et al., 1987).
Since VP1 carries antigenic determinants exposed at
the surface of the virus particle as well as the aa resi-
dues interacting with host cell receptors, alterations af-
fecting VP1 modify such parameters as virus plaque size,
host range, and tumorigenicity (Freund et al., 1991;
Mezes and Amati, 1994; Tooze, 1980). However, VP1 may
exert several functions besides that of carrying viral DNA
from one cell to the next. Modulation of posttranslational
modification accounts for the existence of several spe-
cies of polyoma VP1 with pIs ranging from pH 6.75 to
5.75 (Bolen et al., 1981; Hewick et al., 1977), as also noted
for the VP1 of the closely related SV40 (Brady et al., 1980,
1981; O’Farrell and Goodman, 1976). Finally, a large body
of work indicated that SV40 VP1 carries a function re-
sponsible for the remodeling of viral chromatin which
leads to repression of Ori activity and promoter shut
down; this function is distinct from that involved in capsid
















123RECOMBINATION OF POLYOMA DNA1986; Behm et al., 1988; Dalyot-Herman et al., 1996;
Gordon-Shaag et al., 1998).
Over the past few years, we have studied intramolec-
ular homologous recombination occurring in a polyoma-
mouse DNA chimeric molecule (RmI, 7.1 kb; see Fig. 1)
obtained by triggering excision in a polyoma virus-trans-
formed mouse cell line (Sylla et al., 1984b). Several fea-
FIG. 1. Conversion of RmI into unit-length polyoma virus DNA (Py). (A)
ote that RmI carries a unique viral sequence (line), as well as two 182
p-long direct viral or S repeats (arrowheads), flanking a 1628 bp-long
ouse DNA insert (Ins; gray box). (B). Py arises from RmI by recom-
ining S1 and S2 into one S sequence, while the other S sequence and
he intervening Ins sequence are deleted. (A9) In RmI, the VP1-coding
equence is redundant, consisting of two unique sequences, a and b
(lines), and two identical sequences, s1 and s2 (dots), the latter
ncluded in the S1 and the S2 repeats, respectively (arrowheads). (B9) In
y, the a sequence is linked to the b sequence through a single copy
of the s sequence; since late transcription proceeds counterclockwise
rom the late promoter (LP in A and B), the N-terminal and C-terminal
ortions of VP1 are encoded by a and b, respectively. Note that the
equences encoding VP2 and VP3 (curved arrows) stay unaffected by
ecombination. Ori: polyoma DNA origin. Viral DNA coordinates are
aken from Tooze (1980). Y3 is a binding site for transcription factor YY1
Hariharan et al., 1991; Park and Atchison, 1991; Seto et al., 1991), which
e found to be an enhancer of recombination (Gendron et al., 1996).tures make RmI uniquely useful as a model to study
recombination. (1) As many integrated polyoma ge-nomes, RmI consists of a complete viral genome linked
to host DNA via partly duplicated viral sequences; (2)
RmI is circular and includes a functional viral origin of
replication (Ori) and a complete, functional, early coding
region; hence, RmI replicates autonomously in cells, al-
lowing polyoma virus propagation; (3) even though the
VP1-coding sequence is interrupted by mouse DNA in
RmI, partial duplication of this sequence allows cross-
ing-over to restore the continuity of the VP1-coding gene;
the product of such recombination (Py, 5.3 kb; Fig. 1B) is
thus able to direct the synthesis of VP1 and to initiate the
viral replicative cycle. As those obtained with various
prokaryotic and eukaryotic systems, the data which we
have collected on intramolecular homologous recombi-
nation of RmI suggest the occurrence of a nonconserva-
tive, transcription-dependent process (Nault et al., 1994a,
1994b). We have reported elsewhere data indicating that
while the VP1 gene is interrupted in RmI, expression of a
part of it occurs in the form of a hybrid polyoma-mouse
protein (VmP1), which appears to be required for the
generation of Py from this chimera (Be´langer et al., sub-
mitted for publication). We now report that VP2 is also
required for such generation. Conceivably, VmP1 could
act by bringing VP2 in contact with the recombination
template or, on the contrary, VP2 could be needed to
regulate modification of VmP1, thus activating the latter
protein (Be´langer et al., submitted for publication).
RESULTS
Rationale and experimental strategy
As stated in the Introduction, previous work suggested
that recombination of RmI (Fig. 1) was dependent on
VmP1, a protein including the 328 N-terminal aa of VP1
(Be´langer et al., submitted for publication). Judging from
data available on DNCOVP1, a truncated VP1 in many
ways similar to VmP1 (Garcea et al., 1987), VmP1 was
highly likely to have retained the ability of VP1 to form
pentamers while interacting with VP2 and VP3 (Chen et
al., 1998; Delos et al., 1995). Conceivably, such com-
plexes consisting of VmP1 and VP2, or VmP1 and VP3,
could be translocated to the nucleus, where they would
interact with RmI and stimulate its recombination. There-
fore, our findings concerning VmP1 raised two questions
which we thought might be addressed directly. Were the
so-called minor structural proteins exerting any effect on
the conversion of RmI into Py? If so, was this conversion
affected by VP2, VP3, or both? While the first question
appeared straightforward, the second raised a more
complicated issue. Indeed, whereas either of the minor
structural proteins was likely to assist VmP1 in its trans-
location, and vice-versa, both would presumably facili-
tate virion assembly. In contrast, recombination could
involve specifically the VmP1/VP2 complex or the VmP1/
























124 CHARBONNEAU ET AL.the VP2/VP3 coding sequence by introducing a single
base-pair substitution in RmI at either viral residue 4684
(mutation X), or 4613 (mutation Y), or 4078 (mutation Z;
Fig. 2). The idea was to inactivate selectively VP2 with
mutation X, and both VP2 and VP3 with mutation Y.
Indeed, RmI X was expected to encode a truncated VP2
lacking both a NLS and a VP1-interacting sequence (see
Introduction and Fig. 2), i.e., a protein unable to translo-
cate to the nucleus; in contrast, VP3 would remain intact
(Fig. 2). In the case of RmI Y, both VP2 and VP3 would be
truncated and impaired as VP2 of RmI X. Finally, RmI Z
was expected to encode truncated VP2 and VP3 that
both would lack a NLS (Chang et al., 1992b) but retain the
stretch of aa allowing interaction with VP1 (Fig. 2; Ba-
rouch and Harrison, 1994; Cai et al., 1994) and presum-
ably VmP1 (Garcea et al., 1987).
Quite clearly, we expected that mutation X, or Y, or
possibly all three mutations, would affect the ability of
RmI to yield Py. However, an effect of the mutations on
the ability of the Py recombination product to accumulate
was also a clear possibility. Therefore, we decided from
the start to introduce mutations X, Y, and Z in cloned
FIG. 2. Inserting point mutations in the sequence encoding VP2 and
P3. DNA is shown schematically at the top of the figure. Black boxes
tand for coding sequences of VP1, VP2, and VP3. The coordinate (bp)
arked at left of the boxes is that of the A in the codon for the initiator
ethionine; the coordinate at right of the boxes is that of the T in the
ermination codon (TAA in all three cases). Vertical bars mark the
ocations of the mutations (X, Y, and Z) which we created; the coordi-
ate between brackets is that of the base changed to generate a TAA
top codon: 4684, G to T; 4613, C to A; 4078, G to T. The stretch of 42
a required for the binding of VP2/VP3 to VP1 (Barouch and Harrison,
994) is shown by a horizontal bar labeled “VP1.” Coordinates are taken
rom Tooze (1980). VP2 and VP3, including 319 and 204 aa, respectively,
orizontal bars at the bottom of the figure show the extent of the
runcated proteins that one might expect to be generated from our
utants. Note that mutation X lies outside the VP3-coding sequence
nd mutation Z outside the VP1-coding sequence.polyoma DNA (Py) also, and to assess the phenotypes of
the resulting PyX, PyY, and PyZ. This precaution provedworthwhile, since our characterization demonstrated that
the effect of two of the mutations was more pleitropic
than we had anticipated (see below).
The ability of RmI X, RmI Y, and RmI Z to yield Py is
impaired
RmI, RmI X, RmI Y, and RmI Z were transfected into
mouse cells that were incubated at 37°C for 3 days before
low molecular weight DNA was extracted by the method of
Hirt (1967), electrophoresed, blotted, and annealed with a
radioactive viral DNA probe (Southern, 1975). The autora-
diograms of such blots allowed two major observations
(Fig. 3, Table 1). On one hand, RmI accumulated more
extensively when mutated, an effect the magnitude of
which was maximal for mutation Z and minimal for mutation
X (Z . Y . X, see Table 1). Renewed estimations of DNA
oncentration of the various preparations of plasmids used
n these experiments indicated that these reproducible dif-
erences were not merely reflecting differences in the
mounts of DNA being transfected. On the other hand, any
FIG. 3. Effect of mutations X, Y, and Z on replication/recombination of
RmI. RmI, wild-type or mutant, was transfected (5 mg of circularized
nsert per 10-cm Petri dish) into semiconfluent cultures of 3T6 cells (A)
r Scop-T1 cells (B) that were incubated at 37°C for 3 days (Materials
nd Methods). Low molecular weight DNA was then selectively ex-
racted and digested with EcoRI and DpnI prior to electrophoresis
through a 1% agarose gel. Southern transfers of the gels were hybrid-
ized with a radioactive probe specific for the Py Ori region. Lane 1 was
run with 1024 mg of purified EcoRI-cleaved polyoma virus DNA; Lane 2
was run with a radioactive “ladder” marker, and Lanes 3 to 6 with DNA
from RmI-transfected cells. Note that, going from Lanes 4 to 6, the 7.1-kb
band attributable to RmI progressively increases in intensity. In con-
trast, the Py to RmI ratio is low for all three mutants (compare Lanes 4
to 6 with Lane 3). We deemed it important to carry out this particular
experiment with two different mouse cell lines. On one hand, not all
murine lines generate mostly homologous recombination products; on
the other hand, both Scop-T1 and 3T6 generally do, and with more or




















125RECOMBINATION OF POLYOMA DNAof the mutations reduced the proportion of DNA detectable
as Py, that is, the ratio of Py to RmI. In this case, however,
mutations Y or Z were no more effective than mutation X,
which reduced the yield of Py from RmI about tenfold, on
average (Table 1). The mere fact that the effect on RmI
replication varied with the mutation, whereas the effect on
RmI conversion into Py was rather similar for all mutations,
suggested that the causes for the two effects were not
identical. For instance, accumulation of the RmI precursor
could be negatively regulated by more than one late viral
function or protein, such as VP2, VP3, or even VP1 (see
further); in contrast, removal of a single factor inactivated by
all three mutations, such as VP2, might suffice to strongly
reduce conversion of RmI into Py. While mutations X, Y, and
Z will clearly be shown to strongly affect trans-acting func-
tions, it should already be pointed out here that these
mutations are unlikely to alter DNA replication or DNA
recombination via a cis-acting effect. Indeed, the three
utations are scattered over 400 bp of DNA and consist
ach in the alteration of a single base pair (Fig. 2), the
utation closest to the site of recombination (Z) being still
eparated from repeat S2 by 800 bp (Figs. 1 and 2)
utations X, Y, and Z do not limit accumulation of Py
n transfected cells
Although our data were consistent with VP2 stimulat-
ng recombination in RmI, we could not exclude the
lternative possibility that this protein was stimulating
eplication and thus accumulation of the recombination
roduct (Py) at the expense of that of the recombination
emplate (RmI). Indeed, whereas RmI was too large to
TABLE 1
Accumulation of RmI and Py Following Transfection of Cultured
Mouse Cells with RmI WT, RmI X, RmI Y, and RmI Z
Transfected molecule




A. RmI 3,4232 8,1242 11,547 2.37 6 1.00
B. RmIX 7,6123 1,6203 9,232 0.21 6 0.07
C. RmIY 11,7263 3,8683 15,594 0.33 6 0.10
D. RmIZ 12,0422 2,8272 14,869 0.23 6 0.05
1 The Py to RmI ratio was first calculated for each particular exper-
ment by relating absorbencies of the two bands in the same gel track
see Fig. 3). The various experiments were then compiled to calculate
n average ratio. Even though standard deviations are large, note that
he Py/RmI ratio clearly differs between wild-type on one hand, and
utants on the other. Mouse 3T6 and Scop-T1 cells were used indif-
erently here.
2 Mean of four experiments.
3 Mean of three experiments.ecome encapsidated, VP2 possibly could stabilize Py
y promoting its encapsidation, or be essential to itsamplification through virus propagation. To check the
validity of these rather trivial but real possibilities, muta-
tions X, Y, and Z were introduced into Py, so that the
impact of these mutations on the phenotypes of the
recombination product arising from RmI could be directly
tested (see Rationale and experimental strategy). In a
first series of experiments, the mutant Pys were trans-
fected into mouse Scop-T1 cells which were incubated at
37°C for various lengths of time before analysis of their
content by the Southern procedure. These initial experi-
ments suggested that the efficiency of DNA transfection
and/or recovery varied sufficiently from one sample to
the next to make any real difference between wild-type
and mutant DNAs difficult to demonstrate. From then on,
we cotransfected our Pys with an internal control, i.e., a
molecule possessing a viral Ori making it as readily
amplifiable and detectable as any of our Pys, at least
during the first replicative cycle following transfection.
Thus, cotransfection of Py with pNNOriPy (3.6 kb; see
Materials and Methods) established that there were little
real differences in the accumulation of 5.3-kb viral DNA
between the various Pys, at least over the first 3 days
following transfection (Fig. 4, Lanes 3 to 14). However,
samples taken at the fifth day post-cotransfection al-
lowed three distinct observations. First, Py wild-type pro-
duced a clearly stronger 5.3-kb radioactive band than
mutants Py X and Py Y(Fig. 4, Lane 15 to 17); second, the
5.3-kb band produced by Py Z altogether disappeared
(Fig.4, Lane 18); and third, the 3.6-kb band also disap-
peared, but in all samples (Fig. 4, Lane 15 to 18). On one
hand, the disappearance of the 3.6-kb band attributable
to pNNOriPy was consistent with most cells successfully
transfected dying and coming off the monolayers, thus
escaping Hirt (1967) extraction. On the other hand, the
persistence of a 5.3-kb band in the case of Py, Py X, and
Py Y (Fig. 4, Lanes 15 to 17) was consistent with some
progeny virus completing a second- or third-replicative
cycle in cells still included in the monolayer (see also
next section). However, no such viral propagation oc-
curred with Py Z, the phenotype of which includes an
apparent inability to synthesize or accumulate VP1 (see
results below and Discussion). We concluded from these
experiments that Py X and Py Y replicate and accumulate
as well in transfected cells as wild-type Py and, possibly,
could even initiate some virus propagation. In any case,
the effect of mutations X and Y on Py replication/accumu-
lation was too small, or occurring too late, to account for the
drastic reduction in Py generation from RmI (Fig. 3).
Transfection of mouse cells by Py X and Py Y is
followed by two cycles of hemagglutinin production
To further assess the functionality of the viral genome
in our mutant RmIs, the mutant Pys that we had con-
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126 CHARBONNEAU ET AL.and the appearance of viral hemagglutinin in the cultures
was monitored. Figure 5 shows that from Day 2 post-
transfection, viral hemagglutinin was detectable in cul-
tures transfected with Py, Py X, and Py Y. However, after
the fifth day posttransfection, the titer registered for Py
ascended rapidly, unlike those noted for Py X and Py Y,
which actually tended to decline. In contrast, neither Py
Z nor Py NCVP1, the latter encoding full-size VP2 and VP3
but a VP1 lacking the 26 C-terminal aa of the wild-type
protein (Be´langer et al., submitted for publication), pro-
FIG. 4. Effect of mutations X, Y, and Z on replication/accumulation o
ransfected into mouse Scop-T1 cells that were then incubated for 1, 2, 3
his DNA was analyzed by the Southern (1975) procedure as outline
ofluctuate, except in Lanes 15 to 17, in which the 3.6-kb band altoget
y Y; Z: Py Z. In Lane 14, the faintness of the 5.3-kb band and the absen
f both molecular species.
FIG. 5. Viral hemagglutinin production by cells transfected by Py,
wild-type, or mutant. Recombinant DNAs were digested with SalI and
the cloned viral DNA inserts circularized following incubation with
ligase (Gendron et al., 1988). Subconfluent monolayers of Scop-T1 cells
were transfected (5 mg of circularized insert per 10-cm Petri dishes) and
dishes were frozen at intervals. After thawing and acidification of the
medium, the cell debris were scraped from the bottom of the plates,
collected by centrifugation at 4°C, and subjected to digestion with
receptor destroying enzyme (Crawford, 1962). The titers shown are
those of the clarified extracts. Py NCVP1 is a mutant Py encoding a VP1
lacking the 26 C-terminal aa of this protein (Be´langer et al., submitted
for publication). Note that 4 days posttransfection, the titers reached by
the wild-type on one hand, and mutants X and Y on the other hand,
differ only by a factor of 2.duced detectable hemagglutinin (Fig. 5). Recombinant
DNCOVP1, which carries a C-terminal truncation larger
than that characteristic of Py NCVP1, has been reported
to form in vitro pentamers (capsomers) with hemagglu-
tinin activity comparable to that of whole virus (Garcea et
al., 1987). The fact that Py NCVP1 produced no hemag-
glutinin in this experiment (as well as in several others,
D. Gendron and P. Bourgaux, unpublished observations)
may thus indicate that VP1 pentamers that cannot as-
semble into capsids are not stable in murine cell cul-
tures. If this were the case, the data demonstrated in Fig.
5 could only indicate that Py X and Py Y give rise to
capsids, or even virus particles, as already suggested by
the kinetics of viral DNA accumulation in transfected
cultures (see above and Fig. 4). Actually, careful exami-
nation of the growth curves presented in Fig. 5 suggests
that transfection of wild-type Py is followed by at least
three cycles (A, B, and C) of virus maturation, or hemag-
glutinin production, during the course of the experiment;
indeed, the hemagglutinin titer rises from, respectively,
the first (A), third (B), and fifth (C) day posttransfection
(Fig. 5). Py X and Py Y certainly appear to go through the
first two of these cycles, Cycle A being initiated by the
transfected DNA, and Cycle B initiated necessarily by the
first virus progeny. Although Cycle B would occur with a
reduced efficacy in comparison to wild-type Py, the fact
that Py X and Py Y would go through it at all may appear
surprising at first. Yet, there is a precedent for such
results. Polyoma VP2 is a myristylated protein, such
myristylation being critical to virus viability (Streuli and
Griffin, 1987). A mutant virus has been obtained which
encodes a VP2 not undergoing myristylation; transfection
of its DNA yields whole virus capable of initiating a
single productive cycle, but not indefinite propagation
(Krauzewicz et al., 1990).
ixtures of Py (5.3 kb) with pNNOriPy (3.6 kb) in a 3:1 molar ratio were
ays at 37°C prior to selective extraction of low molecular weight DNA.
g. 3. Note that the intensities of the 5.3- and 3.6-kb bands generally
appears, whereas the 5.3-kb band remains strong. WT: Py; X: Py X; Y:
e 3.6-kb band suggest either inadequate transfection or poor recoveryf Py. M
, or 5 d
d in Fi
her disWe repeatedly tried to propagate virus from receptor-
destroying enzyme (RDE) extracts collected 6 days after
127RECOMBINATION OF POLYOMA DNAtransfection (Fig. 5). Consistently, we succeeded with Py
WT, but not with Py X, Py Y, or Py Z; during our attempts
to passage the mutant genomes, strong bursts of HAU
production were occasionally noted. However, restriction
analysis of the corresponding DNA indicated that these
bursts were due to reversion to wild-type virus (S. Char-
bonneau and P. Bourgaux; unpublished observations).
Synthesis of late proteins following transfection with
Py X, Py Y, and Py Z
To further clarify the phenotype of our mutations, in
particular X and Z, we monitored the production of late
proteins by the various Pys using the Western blotting
procedure. In our initial experiments, we used NP-40
lysates of transfected Scop-T1 cells as source of proteins
to be probed using our immune sera (see Materials and
Methods). Satisfactory results were obtained with this
procedure, although we found background to be variable
but generally high (results not shown). Since Py, Py X,
and Py Y reproducibly yielded viral hemagglutinin in
amounts which differed, but not very markedly (see Fig.
5), we decided to try and demonstrate polyoma structural
proteins starting from receptor-destroying enzyme (RDE)
extracts generally used as a source of infectious virus
(see Materials and Methods). Figure 6 shows results
obtained with this procedure. Use of anti-VP1 antiserum
clearly demonstrates full-size VP1 in all extracts obtained
2 and 4 days following transfection, except for cells
transfected with Py Z (Fig. 6A, Lanes 6 and 10), which
had produced little viral DNA beyond the third day (Fig. 4)
and no hemagglutinin ever (Fig. 5) following transfection.
Absence of VP1 had already been noted in NP-40 lysates
of cells transfected with Py Z (results not shown). In the
case of Py Y, accumulation of VP1 was perhaps some-
what reduced, possibly as a result of limited or delayed
transport of VP1 to the nucleus in the absence of both
VP2 and VP3 (see below and Discussion). As expected,
the use of anti-VP2 antiserum (Fig. 6B) allowed us to
demonstrate VP2 and VP3 in RDE extracts from cells
transfected with wild-type Py. However, none of the ex-
tracts from cells transfected with mutant DNAs appeared
to contain VP2 or VP3 or any protein reacting with the
anti-VP2 serum, except for Py X, which produced VP3 as
expected (Fig. 6B, Lanes 4 and 8). However, we were
puzzled by the fact that the ratio of VP3 to VP1 appeared
considerably less for Py X than for Py WT (Fig. 6, com-
pare Lanes 3 and 4 between A and B). Conceivably, the
reduced amount of VP3 noted for Py X might have re-
sulted from capsid assembly having occurred in the
absence of VP2; this possibility, however, appeared
rather unlikely, since VP3 had not seemed more abun-
dant in extracts of cells transfected with Py X but pre-
pared using NP-40 instead of RDE (results not shown).
As mutation X was the only one expected not to interferewith the translation of one of the minor proteins, VP2 (see
Fig. 2), the results of the Western blot analysis were,
however, entirely consistent with the stop codons intro-
duced into Py X, Py Y, and Py Z interrupting translation of
the VP2/VP3 coding sequence where intended (see Ra-
tionale and experimental strategy) and hence affecting
the stability or immune reactivity of the residual transla-
tion products (see Discussion). Yet, these results also
suggested that mutations X and Z caused more than a
mere interruption of mRNA translation where we had
created a mutant UAA triplet (see Discussion).
DISCUSSION
Phenotype of Py X, Py Y, and Py Z
The three mutations which we have tested for their
influence on the conversion of RmI into Py, and also for
their effect on the ability of Py to replicate and yield
whole virus, all consist of a substitution of a single base
pair in the viral late coding region. The phenotype of
FIG. 6. Western blot analysis of RDE extracts from cells transfected
with Py, wild-type, or mutant. Scop-T1 cells were transfected with Py as
specified in Fig. 5 and incubated for 2 or 4 days (left and right) at 37°C
before being harvested and subjected to RDE extraction. A sample
from the clarified RDE extract was boiled in 2.25% SDS before being
subjected to Western blot analysis (see Materials and Methods). The
blots were probed with either (A) anti-VP1 serum (Be´langer et al.,
submitted for publication) or (B) anti-VP2 serum, the latter a kind gift of
Dr. Richard Consigli. Lanes 1 and 2 were run with an extract from
mock-transfected cells (M) and a mixture of proteins of known molec-
ular weights (L), respectively. The other lanes were run with extracts
from cells transfected with Py (Lanes 3 and 7), Py X (Lanes 4 and 8), Py
Y (Lanes 5 and 9), or Py Z (Lanes 6 and 10). Note that Py X is the only
mutant to give rise to a protein band migrating as VP3 (B, Lanes 4 and
8), while Py Z is the only mutant not to give rise to a protein band
migrating as VP1 (A, Lanes 6 and 10). Upon careful examination of
various exposures of the gel shown in B, no material migrating more
rapidly than the 14.3-kd marker polypeptide (see Lane 2) could be
detected in any of the other lanes.mutation Y is probably the easiest to account for. Muta-


























































128 CHARBONNEAU ET AL.coding region that is expected to interrupt the synthesis
of both VP2 and VP3 and to allow the synthesis of
polypeptides of 129 and 14 aa in place of wild-type
polypeptides of 319 and 204 aa, respectively (Fig. 2). We
have failed to detect full-size VP2 and VP3, as well as
such truncated polypeptides in Western blots from cells
transfected with Py Y and probed with anti-VP2 anti-
serum (Fig. 6B, Lanes 5 and 9), but from such a negative
result we can only conclude that the Y mutation has
indeed affected the production of both VP2 and VP3 as
initially intended. Indeed, there could be several reasons
for our failure to detect truncated forms of VP2 and VP3.
First, the residual 14 aa peptide from VP3 is most prob-
ably too short to be readily detectable under our exper-
imental conditions. Second, the antiserum may not have
contained antibodies reacting with the 129 aa polypep-
tide, since the latter would consist mostly of residues
representing the N-terminal portion of VP2 (Fig. 2), which
appears to be of reduced immunogenicity (Forstova et
al., 1993). Third, neither of these polypeptides bears a
VP1-interacting sequence or a NLS (see Introduction and
Fig. 2), both of these features being important for trans-
location of VP2 and VP3, and perhaps indirectly and to a
lesser extent, for that of VP1 (Fig. 6A, Lanes 5 and 9).
Since truncated VP2 and VP3 probably are rapidly de-
graded in the cytoplasm, the functions encoded by the
VP2/VP3 gene are thus expected to be totally inactivated
by the Y mutation. Yet, in cultures transfected with Py Y,
and at least up to the fourth day posttransfection, viral
DNA replicates and accumulates (Fig. 4), while VP1 also
accumulates (Fig. 6A, Lanes 5 and 9) and viral hemag-
glutinin is produced in increasing amounts (Fig. 5). Alto-
gether, these data suggest that Py Y replicates normally
after transfection and may even yield virus particles of
low specific infectivity.
We anticipated that mutation X would result in the
truncation and thus the inactivation of VP2, while leaving
untouched the synthesis of VP3 (Fig. 2). Actually, while Py
X showed no evidence of producing VP2 but produced
VP3, the latter protein was detected in amounts consis-
tent with synthesis being reduced (Fig. 6B, Lanes 4 and
8) in comparison with that of VP3 by Py wild-type (Fig. 6B,
Lanes 3 and 7). We checked the DNA sequence in which
the X mutation had been introduced and noted that this
sequence, which precedes the initiation codon for VP3,
shows a high degree of complementarity for the 59-“leader”
equence of late mRNAs; this structural feature may be
f importance for the synthesis of VP3 (Soeda et al.,
980b). Even though reduced synthesis of the VP3 pro-
ein somewhat complicates the X mutation phenotype,
his mutation remains the most informative of the three
haracterized. Transfection of Py X is followed by a
ormal synthesis of VP1 and a reduced but readily de-ectable synthesis of VP3; in contrast, no truncated VP2
106 aa, Fig. 2) is detectable in the transfected cells,
t
wrobably for reasons similar to those mentioned above
or the Y mutation. It is thus clear that mutation X is the
nly one to completely inactivate a single gene, that
ncoding VP2. This specificity becomes important when
rying to define the requirements for recombination of
mI (see below).
Finally, mutation Z is the most pleiotropic of the three
utations. Whereas only the C-terminal last 11 aa are
xpected to be missing VP2 and VP3 (Fig. 2), neither VP2
or VP3 is detected in Western blots of cells transfected
ith Py Z. Yet the anti-VP2 antiserum which we are using
as already been shown to react with a truncated VP2
issing the C-terminal last 12 aa of this protein (Cai et
l., 1994). Thus, failure to detect VP2 and VP3 could only
ndicate that these proteins did not accumulate in Py
-transfected cells, a finding which coupled with the
oncomitant failure to detect VP1 may seem rather sur-
rising at first. Actually, the phenotype noted may be
ompounded from two distinct defects. On one hand,
utation Z is likely to interfere with the formation of a
airpin loop which may be critical to the stability or
ranslation of an mRNA (see also mutation X), here that
ncoding VP1 (mutation Z lies 4 nt upstream of the
nitiator AUG in the mRNA for VP1, see Fig. 7B in Soeda
t al., 1980a). On the other hand, the fact that VP2 and
P3 encoded by Py Z would lack a NLS while retaining
he VP1–interactive sequence (see Rationale and exper-
mental approach and Fig. 2) could mean that complex
ormation between VP1 and VP2 or VP3 would target all
hree proteins for degradation in the cytoplasm. At any
ate, its inability to express the VP1 gene probably ex-
lains why PyZ, unlike PyX or PyY, disappears rather
uickly from transfected cells (Fig. 4) and makes no
emagglutinin (Fig. 5). It is thus all the more remarkable
hat transfection of Py Z leads to a normal accumulation
f viral DNA during the first 48 h following transfection
Fig. 4, Lanes 6 and 10).
ffects of mutations X, Y, and Z on RmI
Mutation X appears to be that affecting recombination
ost exclusively. Within 3 days posttransfection, the ratio
f product to precursor becomes higher for RmI than for
mI X by a factor of 10 (Fig. 3, Table 1). We believe that
uch a finding indicates that VP2 plays a role in the
ecombination of RmI. It could be argued that synthesis
f VP3 is strongly depressed by the X mutation and that
his too could contribute to RmI X being handicapped
ith respect to recombination. However, it should be
oted that complete inactivation of the VP3 function does
ot seem to make RmI Y less able to recombine than RmI
already is.
Mutations in the VP2/VP3 gene seem to exert a posi-ive effect on DNA accumulation (Fig 3, Table 1) which,
hile obvious in the case of RmI, could also concern its
sM
129RECOMBINATION OF POLYOMA DNAPy recombination product. In the case of the latter, how-
ever, the phenomenon could hardly be noticeable be-
cause of the concomitant opposing effect on recombina-
tion. Evidence has already been presented by others
suggesting that VP2 exerts a negative control on the
level of viral DNA synthesis (Melucci-Vigo et al., 1994).
Conceivably, the negative effect of VP2 on DNA accumu-
lation and its positive effect on recombination could be
linked (see below).
Involvement of viral late functions in recombination
Whereas it is generally believed that replication of
polyomavirus DNA proceeds bidirectionally from a fixed
point (the Ori), evidence of replication via a rolling circle-
type mechanism has also been presented (Bjursell,
1978). Rolling circle-type replication would be expected
to generate DNA molecules consisting of tandem repe-
titions of the viral genome, and such molecules are
actually produced in great abundance following induc-
tion of viral DNA replication in some polyomavirus-trans-
formed permissive cells (Vogt, 1970; Cuzin et al., 1970;
Mulder and Vogt, 1973). If oligomers of the viral genome
were to serve as precursors of virus progeny, they would
have to be processed into monomers either during or
immediately before encapsidation. This could occur via
either a “cut-and-paste” mechanism or, more simply, via
intramolecular recombination, which does not necessar-
ily include a requirement for site recognition. While there
is no evidence to suggest that polyomavirus structural
proteins could directly participate in recombination,
these proteins may create conditions which would make
recombination possible. As alluded to in the Introduction,
characterization of conditional lethal mutants of SV40
indicated that SV40 VP1, a protein highly similar to poly-
oma virus VP1, carries two main functions. One function
is required for complete virus assembly, and the other for
viral chromatin remodeling, a prerequisite to such as-
sembly (Behm et al., 1988). Inactivation of the latter func-
tion by point mutations precludes redistribution of nu-
cleosomes over the whole genome and thus presumably
the condensation of chromatin that is required for en-
capsidation (Ambrose et al., 1986, 1990; Blasquez et al.,
1986). Other experiments from our lab have indicated
that recombination of RmI is dependent on VmP1, a
protein encoded by RmI which includes the N-terminal
four-fifths of VP1, i.e., a portion of VP1 which would
include the aa sequence critical for chromatin remodel-
ing (Be´langer et al., submitted for publication). Since VP2,
which has been shown to stimulate recombination (this
work), is likely to be complexed with VmP1 in the nucleus
of cells transfected with RmI, it will remain to be deter-
mined which roles are played by, respectively, VmP1 and
VP2 in the recombination of RmI. In particular, it would be
interesting to find out whether VmP1 plays any role in
c
trecombination beyond that of, first, assisting VP2 in its
translocation into the nucleus and, second, allowing VP2
to interact with its DNA template.
MATERIALS AND METHODS
Cells and DNAs
The mouse 3T6 and Scop-T1 cells (Rautmann et al.,
1982) were those used previously (Gendron et al., 1988,
1996). DNA from revertant RtsP155 of the tsP155 mutant
of polyoma virus (Gendron et al., 1988) was propagated
as a recombinant plasmid consisting of unit-length viral
DNA (Py) inserted at the unique SalI site of pNN (Gend-
ron et al., 1996). A non-ts RmI (designated here RmI or
RmI WT) was used throughout this work; it was obtained
by exchanging the shorter EcoRI–SalI (bp 1560–2962)
fragment of RmI (Sylla et al., 1984a,b) containing the
mutant sequence for the corresponding fragment from
RtsP155 (Gendron et al., 1988). As RtsP155 (Py), RmI WT
was propagated as a recombinant plasmid (pRmI) in
which the eukaryotic insert was cloned at the SalI site of
pNN (Gendron et al., 1996). Thus, prior to transfection,
RmI, Py, or any mutant molecule derived from them, was
released from recombinant DNA by digestion with SalI
and circularized by treatment with ligase at low DNA
concentration (Nault et al., 1994a). To compare transfec-
tion efficacy between DNA samples, RmI or Py (see, for
instance, Fig. 4) was cotransfected in some experiments
with a recombinant plasmid (pNNOriPy) containing the
Py Ori (bp 5021–212) as well as a polylinker, allowing
linearization by several restriction enzymes, including
EcoRI. A detailed map of pNNOriPy map, as well as the
protocol for construction of this recombinant plasmid,
are available upon request.
Assay for replication/recombination
Transfections were carried out by the DEAE–dextran
procedure of Sussman and Milman (1984). Subsequently,
the transfected cells were incubated at 37°C instead of
33°C previously (Gendron et al., 1996), and DNA extrac-
tion was performed by the Hirt (1967) procedure. Follow-
ing DNA deproteinization (Nault et al., 1994b), input DNA
was fragmented by digestion with DpnI, while molecules
having replicated since transfection were cleaved with
an enzyme introducing a single scission in RmI or Py,
such as EcoRI or EcoRV (Fig. 1). The DNA was then
electrophoresed through an agarose gel, blotted, and
hybridized with a 32P-labeled viral DNA fragment inclu-
ive of the Ori (bp 5021–212, see above).
utagenesis
All mutant RmIs were generated via a PCR-based pro-
edure, whereas mutant Pys were generally produced by




























































130 CHARBONNEAU ET AL.cedure used here was that of Barettino et al. (1994), in
hich two first-generation PCR reactions and one second-
eneration reaction are carried out with a total of four
ligonucleotidic primers, A, B, C, and D. A and B flank on
ither side the sequence to be mutated, while C and D are
artly complementary and carry the mutated sequence. A
nd C on one hand, and B and D on the other, are used in
he first-generation PCRs, with wild-type DNA as template.
he products of these two PCRs are then mixed to serve as
emplate(s) in the second-generation PCR, which is driven
y primers A and B only. The same A primer extending from
iral nt 2188 to 2169 (59-AGACACTGGTACCAAGCGAC-39)
as used for all three constructs, while the same B primer
xtending from viral nt 3404 to 3430 (59-ACTAGATCTATTC-
GTCCTTATCCAGC-39) was used only for the constructs
ncluding mutations X and Y; a primer extending from nt 2669
o 2650 in Ins (Sylla et al., 1984a; 59-TTCCTAGAGATCTG-
ACTGTACTGG-39) was used as B primer for the construct
ncluding the Z mutation. The following oligonucleotides
ere used as C primers: X, nt 4674 to 4700, 59-GGGAC-
TCTTAGTTGTGTAGGTACCGC-39; Y, nt 4603 to 4629, 59-
TCCTGGGAATTATATATCGAGAAGGG-39; Z, nt 4067 to
093, 59-GGGGCCATCTTACTCTATGACTGTTGC-39; and D
rimers: X, nt 4694 to 4674, 59-CCTACACAACTAAGAG-
TCCC-39; Y, nt 4622 to 4605, 59-CGATATAATTCCCAGG-39;
, nt 4085 to 4067, 59-CATAGAGTAAGATGGCCCC-39. For
he last six oligonucleotides listed, the italicized residue is
he mutated one. Following the second-generation PCR, the
mplified DNA was digested with either EcoRI and EcoRV
mutation X or Y), or EcoRI and BglII (mutation Z). The
esulting EcoRI–EcoRV fragment (2746 bp) or EcoRI–BglII
ragment (4418 bp) was then exchanged for its homolog in
RmI (Fig. 1). The X and Y mutations were introduced into
y by a similar exchange of EcoRI–EcoRV fragments; intro-
ucing Z into Py was achieved by replacing the large
indIII fragment of Py (bp 3918–1656, through the Ori) by its
omolog from pRmI, and selecting for a recombinant with
n adequately oriented insert.
equencing
The presence of point mutations in the region coding
or VP2/VP3 was verified by the dideoxy sequencing
ethod (Sanger et al., 1977) using a T7 DNA Polymerase
Sequencing Kit (Amersham Pharmacia Biotech). Electro-
phoresis was carried out with the Macrophor system
(LKB 2010) through 4% acrylamide:bis acrylamide (38:2)
gradient gels (0.2 to 0.7 mm thickness) containing 7 M
urea, at 2000 V (constant voltage). Following migration,
the gel was fixed, dried, and then exposed to X-ray films.
Western blot analysis
Two different methods were used to monitor produc-
tion of polyoma late proteins and/or capsid assembly by
the mutant genomes. In one method, transfected 3T6 or
SScop-T1 cells were treated in 23 NP-40 lysis buffer (283
M KCl, 10 mM MgCl2, 50 mM HEPES, 4 mM EGTA, 0.6%
P-40, 1 ml per 10-cm Petri dish) containing anti-pro-
eases (PMSF 1 mM, aprotinin 2 mg/ml, leupeptin 1 mM,
and pepstatin A 1 mM) for 20 min on ice, then scraped
nd transferred in a prechilled Eppendorf tube. After
elleting the cell debris, 10 ml of supernatant were sub-
jected to SDS-PAGE (Laemmli, 1970), electroblotted to a
PVDF membrane (Hybond-P; Amersham Pharmacia Bio-
tech) using a Transphor Tank transfer unit (Hoefer TE 22
Mighty Small). Membranes were immersed in a solution
of 5% fat-free milk powder in TBST (50 mM Tris, 150 mM
NaCl, 0.1% Tween 20, pH 7.4) and gently rocked overnight
at 4°C; following three washes in TBST, the membranes
were incubated for 1 h with rabbit anti-polyoma VP1
polyclonal antibody (1:2000), or rabbit anti-VP2/VP3 poly-
clonal antibody (1:500), the latter a kind gift of R. Consigli.
The membranes were again washed three times and
then probed for 1 h with anti-rabbit antiserum conjugated
to horseradish peroxidase (HRP; 1:10,000) and analyzed
with an enhanced chemiluminescence detection kit (ECL
Western blotting detection reagents, Amersham Pharma-
cia Biotech). The protein bands were visualized after
exposure of X-rays films.
The second method differs only in the way the protein-
aceous extract was prepared from the Py-transfected
cells. As was done for virus detection (see also below),
cells adhering to the bottom of the Petri dishes were
scraped into the medium, and the whole content (10 ml)
of the dish transferred to a centrifuge tube which was
stored at 4°C overnight. Floating cells were spun down,
and the pellet was resuspended in 100 ml of Tris–saline
olution containing receptor destroying enzyme (1 unit).
fter a 24-h period of incubation at 37°C, the RDE extract
as clarified and 5 ml of the supernatant was mixed in a
:1 ratio with 0.1 M Tris–HCl, pH 6.8, 4.5% SDS, 20%
lycerol, 1.4 M b-mercaptoethanol, 0.2% bromphenol
blue, boiled for 3–5 min, and then subjected to SDS-
PAGE, electroblotting, and immunodetection as de-
scribed above.
Virus detection and quantification
Virus arising from Scop-T1 cells transfected with RmI
r Py (wild-type or mutant) was extracted after various
eriods of time of incubation at 37°C using receptor-
estroying enzyme and assayed for hemagglutinating
ctivity versus guinea-pig red blood cells (Crawford,
962). When virus was undetectable and the purpose of
he experiment was to decide whether or not the trans-
ected molecule could give rise to infectious virus, half of
he extract from a 10-cm Petri dish was used to infect
nother Petri dish containing a subconfluent culture of
cop-T1 cells. After 8 days of incubation at 37°C, virus




131RECOMBINATION OF POLYOMA DNAonce more. When infectious DNA was used in the trans-
fection, final titers in the range of 1 3 104 to 3.6 3 104
hemagglutination units (HAU) per milliliter were gener-
ally observed.
Densitometry
Autoradiograms showing the conversion of RmI into
Py (Fig. 3) were analyzed using Program NIH Image
1.61/68 K. Scanning of the images was carried out with
scanner UMAX VISTA-SCAN 56E using Program VISTA-
SCAN D.A.V. 1.2.2.
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